PIPITÒ, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 318
EU - Europa 209
AS - Asia 89
OC - Oceania 8
SA - Sud America 2
AF - Africa 1
Totale 627
Nazione #
US - Stati Uniti d'America 316
RU - Federazione Russa 131
SG - Singapore 25
IT - Italia 24
HK - Hong Kong 23
IE - Irlanda 17
CN - Cina 13
IN - India 9
AU - Australia 8
FI - Finlandia 8
FR - Francia 8
SE - Svezia 8
JO - Giordania 6
JP - Giappone 6
DE - Germania 5
ID - Indonesia 5
CH - Svizzera 4
CA - Canada 2
GB - Regno Unito 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
CI - Costa d'Avorio 1
EC - Ecuador 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
Totale 627
Città #
Santa Clara 211
Singapore 21
Hong Kong 20
Dublin 17
Ashburn 14
Chandler 11
Kent 11
Florence 8
Marseille 8
Melbourne 8
West Jordan 8
Mumbai 6
Beijing 4
Bern 4
Helsinki 4
Jakarta 4
New York 4
Calenzano 3
Figline Valdarno 3
Lappeenranta 3
Moscow 3
Nishinomiya 3
Osaka 3
Pune 3
Rome 3
Berlin 2
Bremen 2
Fort Worth 2
Los Angeles 2
Montreal 2
Shanghai 2
Shenzhen 2
Abidjan 1
Chiswick 1
Dubai 1
Falkenstein 1
Guangzhou 1
Guayaquil 1
Hillsboro 1
Kilburn 1
Kunming 1
Moncalieri 1
Oslo 1
Romola 1
São Paulo 1
Vientiane 1
Totale 415
Nome #
BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 cases 97
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease 83
Tralokinumab efficacy in a case of dupilumab-resistant severe atopic dermatitis complicated by eczema herpeticum 76
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association? 73
Marie Antoinette syndrome following COVID-19 vaccination 70
Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab 67
Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney disease 59
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets 59
Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound 52
Totale 636
Categoria #
all - tutte 2.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202367 0 0 0 5 7 16 11 5 9 7 0 7
2023/2024134 2 5 10 10 9 25 5 23 2 14 14 15
2024/2025435 15 46 28 73 146 114 12 1 0 0 0 0
Totale 636